Short Interest in BlackRock Health Sciences Trust (NYSE:BME) Declines By 61.4%

BlackRock Health Sciences Trust (NYSE:BME) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 4,900 shares, a drop of 61.4% from the March 15th total of 12,700 shares. Based on an average trading volume of 44,900 shares, the short-interest ratio is presently 0.1 days.

BlackRock Health Sciences Trust Price Performance

Shares of NYSE:BME traded down $0.22 during trading on Wednesday, reaching $35.98. 46,211 shares of the stock were exchanged, compared to its average volume of 40,926. BlackRock Health Sciences Trust has a 1-year low of $34.18 and a 1-year high of $42.64. The stock has a fifty day moving average of $38.76 and a two-hundred day moving average of $39.47.

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Tuesday, April 15th will be paid a $0.2621 dividend. This represents a $3.15 dividend on an annualized basis and a dividend yield of 8.74%. The ex-dividend date of this dividend is Tuesday, April 15th.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

Hedge funds and other institutional investors have recently made changes to their positions in the business. Janney Montgomery Scott LLC increased its holdings in BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after purchasing an additional 9,455 shares in the last quarter. AlphaStar Capital Management LLC purchased a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at approximately $878,000. Hara Capital LLC bought a new stake in BlackRock Health Sciences Trust during the fourth quarter worth $832,000. Wolverine Asset Management LLC raised its position in BlackRock Health Sciences Trust by 29.1% in the 4th quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after buying an additional 24,928 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in BlackRock Health Sciences Trust during the 4th quarter valued at $3,250,000.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.